{
    "doi": "https://doi.org/10.1182/blood.V112.11.2073.2073",
    "article_title": "A High Number of Losses in 13q14 Chromosome Is Associated with a Worse Outcome and Biological Differences in Patients with B Chronic Lymphoid Leukemia. ",
    "article_date": "November 16, 2008",
    "session_type": "Chronic Lymphocytic Leukemia - Biology and Pathophysiology, excluding Therapy",
    "abstract_text": "Background: Cytogenetic abnormalities in B chronic lymphoid leukemia (B-CLL) define groups of patients with different prognosis. Thus, patients with B-CLL and 13q14 deletion display a favourable outcome. However, whether the percentage of cells showing 13q-, as it has been demonstrated in other genetic aberrations such as loss of P53, could influence the prognosis or the biological characteristics of the disease remains unknown. Aim: To analyze the clinical and biological characteristics of B-CLL displaying, at diagnosis, loss of 13q as the sole cytogenetic aberration. Patients, material and methods : A total of 350 patients diagnosed of B-CLL were included. All the clinical data as well as FISH information (13q14, 12, 11q21, 14q32 and 17p13 probes) and molecular studies were carried out. In addition, a gene expression profile from a microarray-based analysis was also performed. Results: One hundred and sixty-two patients (46.3 %) had 13q14 deletion. In 109 out of the 350 cases (31.1 %) loss of 13q was the sole cytogenetic aberration at diagnosis. Interestingly, in the subgroup of patients with \u00b3 80 % of cells with loss of 13q (18 cases, 15.5%), the OS was 143 months (95 % CI: 104 m-154 m), while in the group with < 80 % of losses in 13q, the OS has not been reached (95 % CI: 175 m-253 m). In the multivariate analysis for OS in patients with 13q-, the variables included in the final model were the percentage of losses of 13q14 (P = 0.001) and the presence of B symptoms (P = 0.007). Regarding the time to the first therapy (TFT), in the group with more than 80 % of losses in 13q the median TFT was 134 months while in the group of patients with < 80 % of losses it was 38 months (P = 0.05). In the multivariate analysis for TFT in patients with 13q- the variables selected were unmutated status of IgV H (P = 0.001) and a high level of b 2 microglobulin (P = 0.003). In addition, the gene expression profile showed that patients with a high number of losses in 13q14 had a high proliferation rate, downregulation of genes apoptosis-related, and deregulation of genes related to mitochondrial functions compared to B-CLL patients with low numbers of 13q- cells. Conclusion: B-CLL patients with a high number of losses in 13q14 as the sole cytogenetic aberration display different clinical and biological features: short OS and TFT as well as more proliferation and less apoptosis. Therefore, a quantification of the number of cells showing a genetic abnormality should be included in the study of the prognostic factors of B-CLL.",
    "topics": [
        "chronic lymphocytic leukemia",
        "chromosomes",
        "gene expression profiling",
        "prognostic factors",
        "chromosome abnormality",
        "mitochondria"
    ],
    "author_names": [
        "Jose\u0301-A\u0301ngel Herna\u0301ndez",
        "Ana-Eugenia Rodri\u0301guez",
        "Marcos Gonza\u0301lez",
        "Roci\u0301o Benito",
        "Celia Fontanillo",
        "Virgilio Sandoval",
        "Mercedes Romero",
        "Guillermo Marti\u0301n-Nu\u0301n\u0303ez",
        "Alfonso Garci\u0301a de Coca",
        "Rosa Fisac",
        "Josefina Galende",
        "Isabel Recio",
        "Francisco Ortun\u0303o",
        "Juan-Luis Garci\u0301a",
        "Javier de las Rivas",
        "Norma-Carmen Gutie\u0301rrez",
        "Jesu\u0301s-Maria Herna\u0301ndez",
        "J.F. San Miguel"
    ],
    "author_dict_list": [
        {
            "author_name": "Jose\u0301-A\u0301ngel Herna\u0301ndez",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital Infanta Leonor, Madrid, Spain"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Ana-Eugenia Rodri\u0301guez",
            "author_affiliations": [
                "IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC, Salamanca, Spain"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marcos Gonza\u0301lez",
            "author_affiliations": [
                "Hematologi\u0301a, IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC; Hospital Cli\u0301nico Universitario, Salamanca, Spain"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roci\u0301o Benito",
            "author_affiliations": [
                "IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC, Salamanca, Spain"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Celia Fontanillo",
            "author_affiliations": [
                "IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC, Salamanca, Spain"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Virgilio Sandoval",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital Virgen Blanca, Leo\u0301n, Spain"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mercedes Romero",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital del Ri\u0301o Hortega, Valladolid, Spain"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guillermo Marti\u0301n-Nu\u0301n\u0303ez",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital Virgen del Puerto, Plasencia (Ca\u0301ceres), Spain"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alfonso Garci\u0301a de Coca",
            "author_affiliations": [
                "Hospital Cli\u0301nico Universitario de Valladolid, Valladolid"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosa Fisac",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital General, Segovia, Spain"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Josefina Galende",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital del Bierzo, Ponferrada (Leo\u0301n), Spain"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabel Recio",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital Nuestra Sen\u0303ora de Sonsoles, Avila, Spain"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francisco Ortun\u0303o",
            "author_affiliations": [
                "Hematologi\u0301a, Hospital Morales Meseguer, Murcia, Spain"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan-Luis Garci\u0301a",
            "author_affiliations": [
                "IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC, Salamanca, Spain"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Javier de las Rivas",
            "author_affiliations": [
                "IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC, Salamanca, Spain"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Norma-Carmen Gutie\u0301rrez",
            "author_affiliations": [
                "Hematologi\u0301a, IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC; Hospital Cli\u0301nico Universitario, Salamanca, Spain"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jesu\u0301s-Maria Herna\u0301ndez",
            "author_affiliations": [
                "Hematologi\u0301a, IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC; Hospital Cli\u0301nico Universitario, Salamanca, Spain"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "J.F. San Miguel",
            "author_affiliations": [
                "Hematologi\u0301a, IBMCC, Centro de Investigacio\u0301n del Ca\u0301ncer, Universidad de Salamanca-CSIC; Hospital Cli\u0301nico Universitario, Salamanca, Spain"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-07T15:33:41",
    "is_scraped": "1"
}